Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.13
+0.03 (0.37%)
Jul 23, 2026, 1:27 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $800.4 million as of July 23, 2026. Its market cap has increased by 65.75% in one year.
Market Cap
800.40M
Enterprise Value
438.41M
1-Year Change
65.75%
Ranking
Category
Stock Price
$8.13
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $800.40M, an increase of 6.14%. That is a compound annual growth rate of 0.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 800.40M | 82.16% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 920.88M |
| Geron | 920.58M |
| Arbutus Biopharma | 892.87M |
| Phathom Pharmaceuticals | 888.82M |
| Annexon | 883.93M |
| Theravance Biopharma | 873.31M |
| Odyssey Therapeutics | 868.03M |
| DBV Technologies | 835.25M |